research Analysis of breast health outcomes in women on oral 5-alpha reductase inhibitors: A single-center retrospective cohort study
Oral 5-alpha reductase inhibitors do not increase breast cancer or benign breast disorder risk in women.






Incomplete name
Cedar Park, TX, United States
Düsseldorf, Nordrhein-Westfalen, Germany
Jakarta, Indonesia
Savannah, GA, United States
Barcelona, Catalunya, Spain
Antibes, France